Aveanna Healthcare Holdings Inc.
In the published model solve dated 2026-Q2, anchored at $13.55, Aveanna Healthcare Holdings Inc. (AVAH) is priced for +14.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Private duty nursing, hourly skilled care delivered inside the patient's own home, is 82% of revenue, and the payer base behind it is described in the 10-K as ⟦more than 1,500 distinct payers that include Medicaid managed care organizations⟧ across 38 states. • Gross debt of $1.32 billion leaves operating profit covering the interest bill about 1.9 times, so a year of flat reimbursement rates would be felt by equity holders long before it troubled a lender. • The next thing to watch is preferr
Is AVAH overvalued? See what's priced in →
187 institutional managers reported holding AVAH in 13F filings for the quarter ended 2026-03-31. Together they hold about 89% of the company; the top 10 hold 71%. 35 opened new positions that quarter. Held by Vanguard Group, BlackRock, Nuveen, among others. On the short side, 3.6M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AVAH's share count grew 25.4% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at AVAH over the trailing three years. Absence is a fact about the company, not a signal. 12 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AVAH's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-11 | +4.5% | -36.4% |
| 2023-11-10 | +7.4% | +50.0% |
| 2024-03-15 | -0.8% | +7.3% |
| 2024-05-10 | +3.3% | +27.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AVAH's latest 8-K filings: 2026-08-24 (items 8.01, 9.01); 2026-08-13 (items 7.01, 9.01); 2026-08-13 (items 2.02, 7.01, 9.01); 2026-08-07 (items 5.02); 2026-06-02 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.